tiprankstipranks
Trending News
More News >
Merus NV (MRUS)
NASDAQ:MRUS

Merus (MRUS) Similar Stocks

Compare
418 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Merus
$40.90
$2.96B
-9.35%
15 Buy
0 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$42.97
$2.79B
10.53
52.21%
9 Buy
1 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$35.62
$2.86B
-30.39%
13 Buy
6 Hold
1 Sell
Moderate Buy
Apellis Pharmaceuticals
$17.30
$2.40B
-59.31%
13 Buy
8 Hold
0 Sell
Moderate Buy
Scholar Rock Holding
$30.67
$2.78B
110.79%
8 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$14.02
$2.43B
-52.79%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MRUS
Merus
40.90
-4.95
-10.80%
PTGX
Protagonist Therapeutics
42.97
13.65
46.56%
CRSP
Crispr Therapeutics AG
35.62
-20.03
-35.99%
APLS
Apellis Pharmaceuticals
17.30
-25.71
-59.78%
SRRK
Scholar Rock Holding
30.67
17.03
124.85%
IMVT
Immunovant
14.02
-15.86
-53.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis